Glaxo may face bill for £1 billion
BRITAIN S largest drugs company is facing a bitter pill in the form of a bill from Whitehall that could be for over £1 billion. An independent report on behalf of the Department of Health has revealed that GalxoSmithKline, which has a research headquarter
BRITAIN'S largest drugs company is facing a bitter pill in the form of a bill from Whitehall that could be for over £1 billion.
An independent report on behalf of the Department of Health has revealed that GalxoSmithKline, which has a research headquarters in Stevenage, may have over-charged the NHS by a staggering £280 million a year for at least five years.
GlaxoSmithKline, which sells over £1.3 billion worth of life-saving drugs to the NHS every year, agreed to price cuts in 1999 after talks with the Government.
But the Pharmaceutical Price Regulation Scheme (PPRS) independent arbitration panel, set up by the Department of Health and chaired by Lord Preston of Mile End, allegedly found the company had continued to bill the NHS the full price for another five years after agreeing the price savings.
You may also want to watch:
Fearing the big bill, GlaxoSmithKline has even warned shareholders it may be financially liable for the error if they have to pay back the over-charging.
The company has also gathered a legal team to fight the claim in the high court.
- 1 Where in Hertfordshire are the most incidents of weapon possession?
- 2 Taser video: Officer's actions which left man with injuries 'deemed appropriate'
- 3 Walk-in and booster vaccine slots available this week
- 4 As sewage saga continues, how did our MPs vote?
- 5 Hitchin's Repair Café wants you!
- 6 Singers make positive change by renaming choir
- 7 Stevenage's annual fireworks display returns on Bonfire Night - November 5
- 8 Annual Pride of Stevenage Awards celebrate our local heroes
- 9 Who can get a Covid booster jab and how can I book one?
- 10 Box Wood: 42 acres of ancient woodland sold at auction
A spokesman for GlaxoSmithKline said: "We believe we have delivered in excess of the savings required by the NHS under the 1999 scheme, and have asked to appeal the decision of the arbitration panel.
"In the meantime, we are continuing to work with the Department of Health to resolve the matter.